Akorn Provides Preliminary Unaudited Full Year 2015 Financial Results and Issues 2016 Financial Guidance
22 mars 2016 07h00 HE
|
Akorn, Inc.
- Preliminary 2015 GAAP Revenue of $985 Million - - Preliminary 2015 GAAP EPS of $1.14; Preliminary Adjusted 2015 EPS of $1.93 - - GAAP Revenue of $1.06 - $1.08 Billion Expected in 2016 - -...
Akorn Receives Expected Additional Delinquency Notice From Nasdaq
07 mars 2016 07h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., March 07, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced that, as expected, it has received a notice from the Nasdaq Listing Qualifications Staff stating...
Akorn Announces Conference Call to Provide Business Updates; Partial Prepayment of Term Loan Facility
25 févr. 2016 07h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, announced that it will provide a business update the morning of...
Akorn Announces Conclusion of Audit Committee Independent Investigation
27 janv. 2016 16h34 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Jan. 27, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced that the Audit Committee of Akorn’s Board of Directors concluded its independent investigation into...
Akorn Appoints Greg Lawless as Chief Human Resources Officer
21 janv. 2016 07h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Gregory P. Lawless joined Akorn as Chief...
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
19 janv. 2016 07h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it has launched Buprenorphine and Naloxone...
Akorn Provides Material Updates
14 janv. 2016 17h25 HE
|
Akorn, Inc.
- BDO USA, LLP Engaged as Independent Registered Public Accounting Firm -- Nasdaq Listing Extension Granted Through May 9, 2016 -- Conference Call Scheduled for 8:00 am ET on January 15, 2016 - ...
Akorn Receives Additional Delinquency Notice from Nasdaq
13 nov. 2015 18h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Nov. 13, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced that, as expected, it has received a notice from the Nasdaq Listing Qualifications Staff stating that the...
Akorn Provides Business and Financial Guidance Update
04 nov. 2015 16h05 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today provided an update on the company's ongoing restatement process...
Akorn Provides Update on Alternative Fulfillment Systems
21 oct. 2015 15h10 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Oct. 21, 2015 (GLOBE NEWSWIRE) -- In response to investor and media inquiries, Akorn, Inc. (Nasdaq:AKRX) provided the following update on the company's use of alternative...